Meta-analysis of 26 RCTs (7452 patients) of neoadjuvant therapy for gastroesophageal adenocarcinoma: pathological complete response did not correlate with overall survival at individual (R² 0.006) or trial level (R² 0.060); subgroup surrogacy varied.
Meta-analysisn = 7,452
Leite et al. Is pathological complete response a surrogate for overall survival in neoadjuvant clinical trials for gastroesophageal adenocarcinoma?